Artificial Intelligence

THX unveils Spatial Audio+ at CES 2026, bringing AI head tracking and 7.1.4 surround sound to headphones and laptops for unparalleled gaming and cinema.

United is set to reveal its full-year 2025 earnings, putting its ambitious growth strategy and market leadership claims to the ultimate test.

Inspira Technologies announces a landmark deal to acquire a liquid biopsy firm, securing a $15M investment at a $180M valuation to enter the cancer market.

Limbach Holdings appoints M&A and operations expert Terry Dugan to its board, a strategic move aimed at accelerating growth in mission-critical markets.

Dash cam leader Nextbase is turning millions of drivers into data collectors with its new InSight platform, promising to reshape our cities and roads.

At CES 2026, Silicon Labs launched its Simplicity SDK for Zephyr, bridging open-source flexibility with commercial support for next-gen IoT.

Zocdoc's new 'You've Got Options' campaign uses witty ads to tackle a serious problem: the frustrating search for the right doctor. But can it work?

With a fresh funding series, Clipto.AI is pioneering a privacy-first future where powerful AI processes your sensitive content directly on your device.

Opus Fund Services launches SmartWire, an AI-driven platform designed to automate payments and secure fund managers against fraud and operational risks.

A new firm, Rapid Drone, enters the booming drone market not as a maker, but as a specialized service provider using secure, US-certified aircraft.

Future FinTech and quant firm S1Quant partner to build a compliant bridge for institutional investors into the volatile world of cryptocurrency assets.

As media giants face a fragmented ad landscape, Operative's new AOS Services Platform aims to unify linear and digital revenue with an AI-driven core.

At CES 2026, Ubicept's new toolkit promises to let AI see clearly in the dark and at high speed, ushering in a new era for robotics and autonomous cars.

BridGene Biosciences adds Nobel winner Dr. Bruce Beutler to its board, gaining immense credibility for its mission to create drugs for intractable diseases.

Founder Chuck Cohn pours millions more into his ed-tech firm, a bold move that signals deep confidence despite a slumping stock and cautious analysts.

With a hot obesity pipeline and a key neurology asset, Nxera Pharma's J.P. Morgan talk is a crucial test of its plan for global leadership.

William Healey, a 25-year veteran, takes the helm as IAAO's 2026 President, guiding the future of global property valuation amid technological change.

With a $257M war chest and a veteran team, BlossomHill will showcase its innovative pipeline for lung cancer and leukemia at the pivotal JPM conference.

With surging revenue for its cholesterol drugs and new guideline backing, Esperion outlines its strategy for profitability and pipeline expansion.

With stunning clinical data for its miv-cel therapy, Kyverna is set to outline a new era for autoimmune treatment at the J.P. Morgan conference.